{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:17:54Z","timestamp":1788675474343,"version":"build-2803163510"},"reference-count":22,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2025]]},"DOI":"10.70352\/scrj.cr.24-0096","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T22:12:41Z","timestamp":1741644761000},"page":"n\/a","source":"Crossref","is-referenced-by-count":1,"title":["Salvage Lung Resection of Aspergilloma Mimicking Tumor Regrowth after Immune Checkpoint Inhibitor Therapy for Stage IV Squamous Cell Lung Cancer: A Case Report"],"prefix":"10.70352","volume":"11","author":[{"given":"Takahiro","family":"Utsumi","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Kansai Medical University, Hirakata, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruaki","family":"Hino","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Kansai Medical University, Hirakata, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Takeyasu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Kansai Medical University, Hirakata, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Maru","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Kansai Medical University, Hirakata, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Kansai Medical University, Hirakata, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Kansai Medical University, Hirakata, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohito","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Kansai Medical University, Hirakata, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayasu","family":"Kurata","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Kansai Medical University, Hirakata, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tsuta","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kansai Medical University, Hirakata, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Murakawa","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Kansai Medical University, Hirakata, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Chaft JE, Hellmann MD, Velez MJ, et al. Initial experience with lung cancer resection after treatment with T-cell checkpoint inhibitors. Ann Thorac Surg 2017; 104: e217\u20138.","DOI":"10.1016\/j.athoracsur.2017.03.038"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hino H, Utsumi T, Maru N, et al. Results of emergency salvage lung resection after chemo- and\/or radiotherapy among patients with lung cancer. Interact Cardiovasc Thorac Surg 2022; 35: ivac043.","DOI":"10.1093\/icvts\/ivac043"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228\u201347.","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Schreiner W, Dudek W, Lettmaier S, et al. Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? J Cardiothorac Surg 2016; 11: 9.","DOI":"10.1186\/s13019-016-0396-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Forde PM, Chaft JE, Smith KN, et al. Neoadjuvant PD-1 blockade in resectable lung cancer. N Engl J Med 2018; 378: 1976\u201386.","DOI":"10.1056\/NEJMoa1716078"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Berzenji L, Van Schil PE. Salvage lung surgery in long-term survivors after biological and immunotherapeutic treatments. Shanghai Chest 2021; 5: 24.","DOI":"10.21037\/shc-2019-rpts-25"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Smith A, Wali A, Montes A, et al. Salvage pulmonary resection in stages IIIb-IV lung cancer after treatment with immune checkpoint inhibitors case series and literature review. J Surg Oncol 2022; 125: 290\u20138.","DOI":"10.1002\/jso.26691"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Uramoto H. Current topics on salvage thoracic surgery in patients with primary lung cancer. Ann Thorac Cardiovasc Surg 2016; 22: 65\u20138.","DOI":"10.5761\/atcs.ra.16-00019"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ueno T, Yamashita M, Yamashita N, et al. Safety of salvage lung resection after immunotherapy for unresectable non-small cell lung cancer. Gen Thorac Cardiovasc Surg 2022; 70: 812\u20137.","DOI":"10.1007\/s11748-022-01798-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Higuchi M, Inomata S, Yamaguchi H, et al. Salvage surgery for advanced non-small cell lung cancer following previous immunotherapy: a retrospective study. J Cardiothorac Surg 2023; 18: 235.","DOI":"10.1186\/s13019-023-02310-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Goto E, Hattori A, Fukui M, et al. Salvage extended surgery after immune-checkpoint inhibitor treatment for advanced non-small cell lung cancer. Surg Today 2024; 54: 917\u201326.","DOI":"10.1007\/s00595-024-02812-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Dickhoff C, Unal S, Heineman DJ, et al. Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer. Lung Cancer 2023; 182: 107294.","DOI":"10.1016\/j.lungcan.2023.107294"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Beattie R, Furrer K, Dolan DP, et al. Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes. Eur J Cardiothorac Surg 2021; 60: 1297\u2013305.","DOI":"10.1093\/ejcts\/ezab340"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Bott MJ, Yang SC, Park BJ, et al. Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer. J Thorac Cardiovasc Surg 2019; 158: 269\u201376.","DOI":"10.1016\/j.jtcvs.2018.11.124"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hamaji M, Ozasa H, Yoshizawa A, et al. Salvage thoracoscopic resection after nivolumab for stage IV. Asian Cardiovasc Thorac Ann 2020; 28: 216\u20138.","DOI":"10.1177\/0218492320919477"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Lobinger D, Hiebinger A, Eicher F, et al. Rescue surgery in palliative indication as last therapeutic option for complicated advanced stage lung cancer. Eur J Surg Oncol 2023; 49: 107253.","DOI":"10.1016\/j.ejso.2023.107253"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Curioni-Fontecedro A, Ickenberg C, Franzen D, et al. Diffuse pseudoprogression in a patient with metastatic non-small-cell lung cancer treated with nivolumab. Ann Oncol 2017; 28: 2040\u20131.","DOI":"10.1093\/annonc\/mdx233"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Murao K, Mori Y, Takahashi Y, et al. Simultaneous pseudoprogression and an immune-related adverse event of pulmonary pleomorphic carcinoma after combined therapy with cytotoxic anticancer agents and immune checkpoint inhibitor. Intern Med 2022; 61: 3259\u201364.","DOI":"10.2169\/internalmedicine.8916-21"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Itano H, Andou A, Date H, et al. Non-small cell lung cancer coexisting with pulmonary aspergilloma. Jpn J Thorac Cardiovasc Surg 2005; 53: 513\u20136.","DOI":"10.1007\/s11748-005-0099-2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) McCarthy DS, Pepys J. Pulmonary aspergilloma\u2014clinical immunology. Clin Exp Allergy 1973; 3: 57\u201370.","DOI":"10.1111\/j.1365-2222.1973.tb01310.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Denning DW, Cadranel J, Beigelman-Aubry C, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016; 47: 45\u201368.","DOI":"10.1183\/13993003.00583-2015"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Temes RT, Willms CD, Endara SA, et al. Fissureless lobectomy. Ann Thorac Surg 1998; 65: 282\u20134.","DOI":"10.1016\/S0003-4975(97)01268-X"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.24-0096\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T05:06:16Z","timestamp":1742015176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.24-0096\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.24-0096","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"cr.24-0096"}}